Search Results 361-370 of 17347 for hydroxychloroquine

  1. A Study to Assess Frailty and Its Impact on Patients with Pulmonary Hypertension - Mayo Clinic

    The purpose of this study is to evaluate the prevalence and effect of frailty in patients referred to pulmonary hypertension (PH) clinic at our institution.

  2. Can vitamin D protect against coronavirus disease 2019 (COVID-19)? - Mayo Clinic

    Is hydroxychloroquine a treatment for COVID-19? Long COVID: Lasting effects of COVID-19 · Mayo Clinic Minute: How dirty are common surfaces? Mayo Clinic ...

  3. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

    About this study. The purpose of this study is to confirm and extend the results observed in the Phase 1 and 2a studies with BMS-986036.

  4. Cirrhosis Clinical Trials - Mayo Clinic Research

    This is a pilot study to see if hydroxychloroquine (HCQ) if safe and effective to use with patients having cramps due to their cirrhotic liver disease.

  5. Safety tips for attending school during COVID-19 - Mayo Clinic

    Is hydroxychloroquine a treatment for COVID-19? Long COVID: Lasting effects of COVID-19 · Multisystem inflammatory syndrome in children (MIS-C) · Pregnancy and ...

  6. Undigested food in stool: What does it mean? - Mayo Clinic

    Is hydroxychloroquine a treatment for COVID-19? Listeria infection · Long COVID: Lasting effects of COVID-19 · Managing Headaches · Mantle cell lymphoma · Mayo ...

  7. Mayo experts encouraged by authorization of first pill to treat COVID-19

    Paxlovid, which is made by Pfizer, is the first oral antiviral medication authorized to help people who are infected with COVID-19 before they are hospitalized.

  8. Endocrinology - Doctors - Mayo Clinic

    Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.

  9. Massage Therapy at Mayo Clinic

    An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20170394.

  10. Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia - Mayo Clinic

    Prior exposure to cisplatin, 5-fluorouracil, tamoxifen, and/or MEK inhibitors within 3 months of enrollment and/or ethambutol and/or hydroxychloroquine within ...